TAK R&D Expenses
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) · R&D Expenses
TAK R&D Expenses
Latest reported¥706.18B JPYperiod ending
TAK R&D Expenses · JPY (¥0.00 → ¥706.18B)
Annual R&D Expenses
High-resolution chart · PNG
TAK r&d expenses history
Annual fiscal periods · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (JPY) |
|---|---|
| 716,687,520,000 | |
| 730,227,000,000 | |
| 729,924,000,000 | |
| 633,325,000,000 | |
| 526,087,000,000 | |
| 455,833,000,000 | |
| 492,381,000,000 | |
| 368,298,000,000 | |
| 325,441,000,000 | |
| 312,303,000,000 | |
| 345,927,000,000 | |
| 382,096,000,000 | |
| 341,560,000,000 | |
| 324,292,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |